Apex Bioscience deal

Apex received exclusive rights outside of Japan to Ajinomoto Co. Inc.'s pyridoxylated hemoglobin polyoxyethylene conjugate (PHP) to treat disorders related to excess nitric oxide. Ajinomoto (Tokyo) transferred its U.S. IND to Apex (Research Triangle Park, N.C.), which expects to enter in June Phase I trials of PHP to treat acute hypotension in septic shock. Financial terms weren't disclosed. ...